Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
-
641
-
642
-
643
-
644
-
645
-
646
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
647
-
648
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
649
-
650
-
651
-
652
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
653
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
654
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
655
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
656
-
657
-
658
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
659
-
660